Back

The role of galectin-3 in obese patients with heart failure

25 May 2019 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Diagnostic Methods Diagnostic Methods HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Alexandra Dadarlat-Pop

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca (Romania)

22 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Doctor B. Li (Basildon, GB)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Doctor J. Spyropoulos (Purchase, US)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Diagnostic Methods

The Event

Event poster

Heart Failure 2019

25 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Galectin-4 is associated with diabetes in a heart failure population
22 May 2023
thumbnail
Congress Session
When and how to treat obesity in heart failure
18 May 2025
thumbnail
Congress Presentation
Exploring the role of galectin-3 and pentraxin-3 as biomarkers in chronic coronary syndrome with atrial fibrillation: insights from an 87-patient cohort
30 August 2025
thumbnail
Congress Presentation
Features of changes in the level of profibrotic factors and their relationship with parameters of left ventricular mechanics in epicardial obesity
30 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources